Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666129
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2020-12-07
Brief Title:
Study of Relugolix in Men with Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Sumitomo Pharma Switzerland GmbH
Organization:
Sumitomo Pharma Switzerland GmbH
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-29
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-07
First Submit QC Date:
December 7 2020
Study First Post Date:
2020-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL